WHO technical report on monitoring timepoints in adult patients treated for HCV with pegylated interferon alpha and ribavirin
World Health Organization. (2014). WHO technical report on monitoring timepoints in adult patients treated for HCV with pegylated interferon alpha and ribavirin. World Health Organization. http://www.who.int/iris/handle/10665/133737
Annex to Guidelines for the screening, care and treatment of persons with hepatitis C infection ISBN 9789241548755
Gov't Doc #WHO/HIV/2014.26
MetadataShow full item record
Showing items related by title and MeSH subject.
PICO 6: treatment: pegylated interferon plus ribavirin versus standard interferon plus ribavirin for chronic hepatitis C infection: a meta-analytical systematic review World Health Organization (WHO/HIV/2014.32, 2014)
Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major Saffar, M.J.; Saffar, H.; Khalilian, A.R.; Naqshvar, F. (2009)Treatment of chronic hepatitis C virus [HCV] infection in transfusion-dependent betathalassaemia major patients is complicated by existing hepatic siderosis and the fear of ribavirinassociated haemolysis. We evaluated the efficacy and side-effects of combination interferon-alpha [INF] and ribavirin therapy for HCV-infected thalassaemia patients. A total of 17 patients were enrolled [10 nonresponders to INF monotherapy, 7 naive to treatment, mean age 23.1 years] and they received 12 months of combination therapy. The sustained virological response ...
PICO 7: treatment: direct acting antiviral therapy versus pegylated interferon and ribavirin treatment for chronic hepatitis C infection: a meta-analytical systematic review World Health Organization (WHO/HIV/2014.33, 2014)